GlassScriptPhysician profile
Steven Scarcliff
NPI 1710168745
$4,271.73
in general payments reported to CMS, 2019-2025
26 companies · $676 in 2025
The $676 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $262 · 2021: $170 · 2022: $761 · 2023: $863 · 2024: $842 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,380.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $962.88 | 2021-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $740.56 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $571.41 | 2021-2025 | Vistaseal, Enseal, Harmonic |
| Conmed Corporation | $314.17 | 2019-2024 | Conmed Generators, Conmed Biliary |
| Stryker Corporation | $174.55 | 2023 | Spy-Phi System |
| Wound Management Technologies, INC | $144.21 | 2019 | |
| Abbvie INC. | $141.91 | 2024 | |
| Zimmer Biomet Holdings, INC. | $123.96 | 2023 | Ribfix Blu Advantage |
| Integra Lifesciences Corporation | $122.40 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Acell, INC. | $119.28 | 2020 | |
| La Jolla Pharmaceutical Company | $108.06 | 2022 | |
| Acera Surgical, INC. | $102.71 | 2019 | |
| Springworks Therapeutics, INC. | $87.10 | 2024 | Ogsiveo |
| Osiris Therapeutics INC. | $78.67 | 2019 | |
| Histosonics, INC. | $74.73 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $70.81 | 2019-2022 | |
| Solventum Corporation | $69.13 | 2024-2025 | V.A.C. Veraflo, Abthera, Prevena |
| Kerecis Limited | $52.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Angiodynamics, INC. | $44.34 | 2023 | Nanoknife |
| Smith+Nephew, INC. | $36.01 | 2020 | |
| Ambu INC. | $29.15 | 2022 | |
| Medtronic, INC. | $24.24 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $23.58 | 2025 | |
| Thd America, INC. | $20.29 | 2024 | |
| Tela Bio, INC. | $19.84 | 2024 | Ovitex 2s |
| Axonics, INC. | $15.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Scarcliff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.